Production (Stage)
HOOKIPA Pharma Inc.
HOOK
$1.53
-$0.03-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -94.52% | -81.72% | -31.51% | -51.85% | 1,052.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -94.52% | -81.72% | -31.51% | -51.85% | 1,052.36% |
| Cost of Revenue | -36.24% | -41.20% | -36.79% | -49.35% | -3.65% |
| Gross Profit | -166.06% | 17.01% | 38.83% | -52.17% | 192.54% |
| SG&A Expenses | 69.77% | 20.03% | 37.05% | -11.25% | -17.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.49% | -27.48% | -24.51% | -1.89% | -6.23% |
| Operating Income | -243.36% | 5.32% | 22.39% | -4.34% | 154.62% |
| Income Before Tax | -207.26% | -1.63% | 27.40% | -5.99% | 173.85% |
| Income Tax Expenses | -- | -164.63% | -- | -- | -- |
| Earnings from Continuing Operations | -207.26% | -0.53% | 27.40% | -5.99% | 173.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -207.26% | -0.53% | 27.40% | -5.99% | 173.08% |
| EBIT | -243.36% | 5.32% | 22.39% | -4.34% | 154.62% |
| EBITDA | -233.32% | 2.29% | 23.84% | -5.26% | 159.88% |
| EPS Basic | -207.72% | 9.56% | 36.09% | 30.09% | 141.90% |
| Normalized Basic EPS | -198.13% | -57.10% | 40.94% | 30.29% | 146.07% |
| EPS Diluted | -207.89% | 9.56% | 36.09% | 30.14% | 141.83% |
| Normalized Diluted EPS | -198.13% | -57.10% | 40.94% | 30.29% | 146.07% |
| Average Basic Shares Outstanding | -0.42% | 11.16% | 13.59% | 51.61% | 74.44% |
| Average Diluted Shares Outstanding | -0.42% | 11.16% | 13.59% | 51.61% | 74.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |